John Bomalaski
Corporate Officer/Principal chez POLARIS GROUP
Postes actifs de John Bomalaski
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| POLARIS GROUP | Corporate Officer/Principal | 01/01/2007 | - |
| Directeur/Membre du Conseil | 15/04/2006 | - | |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Directeur Technique/Scientifique/R&D | - | - |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
| Directeur Technique/Scientifique/R&D | 18/12/2009 | - | |
| DRX USA | Directeur/Membre du Conseil | - | - |
| DesigneRx Europe Ltd. | Directeur/Membre du Conseil | - | - |
| Polaris Group Korea Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de John Bomalaski
Anciens postes connus de John Bomalaski
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - | - |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - | - |
Formation de John Bomalaski
| St. Louis University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Espagne | 2 |
| Îles Cayman | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Entreprise privées | 5 |
|---|---|
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DRX USA | |
| DesigneRx Europe Ltd. | |
| Polaris Group Korea Ltd. |
- Bourse
- Insiders
- John Bomalaski
- Expérience
